Exposure-Response Analysis for Mavrilimumab Phase2b Study in RA Patients with Informative Dropout.

ARTHRITIS & RHEUMATOLOGY(2014)

Cited 0|Views7
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined